Oragenics Launches EvoraPlus™ Oral Care And Teeth Whitening Probiotic Product
Leading Florida-Based Biopharmaceutical Company Develops The Industry’s First 100% Natural All-In-One Probiotic Mint That Gently Whitens Teeth And Alleviates Bad Breath While Supporting Gum And Tooth Health
Alachua, FL– Florida-based biopharmaceutical leader Oragenics, Inc. (OTCBB: ORNI www.oragenics.com) has launched EvoraPlus™, the first-ever all-natural probiotic teeth whitening mint specifically designed for complete oral care. EvoraPlus represents the first time probiotics, which have traditionally been used to support digestive and immune health, have been applied for whitening teeth and eliminating bad breath while promoting gum and tooth health.
EvoraPlus naturally whitens teeth (up to three to four shades within the first month). At the same time, as a result of its proprietary harmful bacteria-fighting science, EvoraPlus supports optimal gum and tooth health while freshening breath and whitening teeth.
Developed by Oragenics Chief Scientific Officer, Dr. Jeffrey Hillman, D.M.D., Ph.D., EvoraPlus™ is the result of more than 25 years of research into the creation of Oragenic’s proprietary probiotic blend, ProBiora3 which began at the Harvard-affiliated Forsyth Institute in Boston and continued at the University of Florida. The technology has only recently become available for the general public.
Dental disease is a quiet, yet growing, national epidemic. New studies, including recently-published reports from the Mayo Clinic, confirm that periodontal disease and poor oral health are linked to heart disease, diabetes, osteoporosis, and other illnesses. American Dental Association studies show that three out of four of Americans are affected by periodontal disease at some point in their lives.
“People tend to take a simple approach to oral care in our culture,” says Dr. Hillman, who has authored more than 125 publications on subjects related to the etiology and prevention of cavities, periodontal diseases and other infectious diseases and cancer. “We think in terms of killing all of the bacteria that are present in the mouth. But it’s just not that simple; the human mouth contains many different types of bacteria, including some that are helpful to us.”
The ProBiora3 blend of beneficial bacteria used in EvoraPlus provides a deep impact by helping to maintain the oral flora in a healthy balance using a simple, non-invasive daily routine. When the EvoraPlus mint melts on the tongue, the freeze-dried probiotics activate and attach themselves to the teeth and gum tissue, establishing colonies of active bacteria both on the surface of the teeth and deep beneath the gum line. These colonies compete for nutrients and interfere with the harmful oral bacteria that disrupt gum and tooth health, and also cause bad breath.
“There really is no other technology currently available or on the horizon that offers the same benefits that EvoraPlus offers,” says Dr. Hillman. “Completely natural, EvoraPlus is safe and easy to use. It’s a completely natural approach that offers the added benefits of promoting fresh breath and whitening teeth.” Other products, such as mouth rinses, are temporary and topical in their nature. EvoraPlus stays with you the entire day. Importantly, EvoraPlus can work with people who wear braces, dentures, caps or veneers.”
EvoraPlus is available through EvoraPlus.com as well as top Internet retailers including Drugstore.com, Walgreens.com, Target.com and CVS.com. In addition, EvoraPlus is available via such prestigious national retailers and distributors as A&P, Pathmark, Kerr Drug, Cardinal Health, HD Smith and Swansonhealth.com.
About Dr. Hillman
Dr. Jeffrey Hillman founded Oragenics, Inc., to commercialize the fruits of 25 years of research at the Harvard-affiliated Forsyth Institute in Boston and the University of Florida. Currently a professor emeritus at the University of Florida, College of Dentistry, Dr. Hillman has continued his work at Oragenics on final development of several cutting-edge health technologies. Dr. Hillman has authored or co-authored more than 125 publications and textbook chapters on subjects related to the etiology and prevention of caries (cavities), periodontal (gum) diseases and other infectious diseases and cancer. Dr. Hillman received his undergraduate training at the University of Chicago, his DMD degree from the Harvard School of Dental Medicine, and his Ph.D. from Harvard Medical School.
About Oragenics, Inc
Oragenics, Inc., is a biopharmaceutical company engaged in developing unique proprietary technologies, some of which are being commercialized and sold in the over-the-counter consumer healthcare market. The company also has a number of products in discovery, preclinical and clinical development, with a concentration in the main therapeutic area of infectious diseases, diagnostics and oral health. The company is located in Progress Corporate Park at 13700 Progress Boulevard in Alachua, Florida, approximately 15 miles from the campus of the University of Florida in Gainesville.
For more information about EvoraPlus, visit www.evoraplus.com.